Patents by Inventor Michael A. McCutcheon

Michael A. McCutcheon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus and method of treating an approaching physiological event and increasing an intensity of the event
    Patent number: 11963901
    Abstract: A flexible neuromodulation device and method capable of varying a neuromodulation therapy in order to prevent, delay, or control a sexual emission, and/or increasing an intensity of a sexual climax.
    Type: Grant
    Filed: December 28, 2020
    Date of Patent: April 23, 2024
    Inventors: Jeffrey Bennett, Shawn McCutcheon, Michael F. Hoey, Rachel Goldstein, Dicken S. C. Ko
  • APPARATUS AND METHOD OF TREATING AN APPROACHING PHYSIOLOGICAL EVENT AND INCREASING AN INTENSITY OF THE EVENT
    Publication number: 20240074888
    Abstract: A flexible neuromodulation device and method capable of varying a neuromodulation therapy in order to prevent, delay, or control a sexual emission, and/or increasing an intensity of a sexual climax.
    Type: Application
    Filed: November 14, 2023
    Publication date: March 7, 2024
    Inventors: Jeffrey Bennett, Michael Hoey, Shawn McCutcheon, Rachel Goldstein, Dicken S.C. Ko
  • Method for monitoring T cell reactivity
    Patent number: 6218132
    Abstract: This invention provides a highly sensitive assay for the detection of T-cells reactive to an antigen by detecting a soluble factor whose secretion is induced by stimulation of the T-cell by the antigen. The assay includes an antigen-driven proliferation of specific T cells prior to restimulation with irradiated antigen presenting cells (APCs) and antigen. In exemplary embodiments the assay is used to enhance the detection limits of human peripheral blood mononuclear cells (PBMCs) secreting interferon-&ggr; (IFN-Y) and interleukin-2 (IL-2). The assay can be performed on previously frozen PBMCs, providing greater convenience in sample processing, multiple use of a single sample as an internal standard, and simultaneous analysis of samples collected at different time points.
    Type: Grant
    Filed: November 24, 1997
    Date of Patent: April 17, 2001
    Assignee: Anergen, Inc.
    Inventors: Edward G. Spack, Nancy G. Wehner, Michael A. McCutcheon
  • Method for monitoring T cell reactivity
    Patent number: 5750356
    Abstract: This invention provides a highly sensitive assay for the detection of T-cells reactive to an antigen by detecting a soluble factor whose secretion is induced by stimulation of the T-cell by the antigen. The assay includes an antigen-driven proliferation of specific T cells prior to restimulation with irradiated antigen presenting cells (APCs) and antigen. The assay can be performed on previously frozen PBMCs, providing greater convenience in sample processing, multiple use of a single sample as an internal standard, and simultaneous analysis of samples collected at different time points.
    Type: Grant
    Filed: May 31, 1996
    Date of Patent: May 12, 1998
    Assignee: Anergen, Inc.
    Inventors: Edward G. Spack, Nancy G. Wehner, Michael A. McCutcheon